Concepedia

Kashfia Chowdhury

KC

15

Publications

1.8K

Citations

14

H-Index

2013

Active since

Affiliations

University College London(Current)

University of Surrey

National Hospital for Neurology and Neurosurgery

Queen Mary University of London

University College London Hospitals NHS Foundation Trust

Kashfia Chowdhury is an author at University College London specializing in psychopharmacology, clinical trials, and rehabilitation.

ORCID

Top concepts

Publications per year

2013–2025

15

Publications

15

Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial

Dilan Athauda, Kate Maclagan, Simon S. Skene et al. · The Lancet · 2017 · 811 citations

, , +8

Utility of Neuronal-Derived Exosomes to Examine Molecular Mechanisms That Affect Motor Function in Patients With Parkinson Disease

Dilan Athauda, Seema Gulyani, Hanuma Kumar Karnati et al. · JAMA Neurology · 2019 · 244 citations · Full text

Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial

Nirosen Vijiaratnam, Christine Girges, Grace Auld et al. · The Lancet · 2025 · 83 citations · Full text

Exenatide once weekly over 2 years as a potential disease-modifying treatment for Parkinson’s disease: protocol for a multicentre, randomised, double blind, parallel group, placebo controlled, phase 3 trial: The ‘Exenatide-PD3’ study

Nirosen Vijiaratnam, Christine Girges, Grace Auld et al. · BMJ Open · 2021 · 76 citations · Full text

Effect of Corneal Cross-linking versus Standard Care on Keratoconus Progression in Young Patients

Frank Larkin, Kashfia Chowdhury, Jennifer Burr et al. · Ophthalmology · 2021 · 75 citations · Full text

Rows per page

1–5 of 15